GLP-1s During a Cut: What Happens to Muscle Mass?

[AnneLifts]

GLP-1 induced weight loss includes both fat and lean mass. Lean mass is only a small part of the total weight lost, and DEXA scans can't tell muscle protein apart from water, glycogen, or connective tissue. So, you can't say for sure that lean mass loss means muscle loss. Any aggressive calorie deficit will lead to some lean tissue loss, whether you're using a drug or not. How much lean mass you lose depends on how fast you lose weight, your protein intake, and your resistance training. The people in these trials are very different from trained lifters, and that matters a lot.

How GLP-1 Weight Loss Actually Breaks Down​

If you look past the marketing, the GLP-1 weight loss number is really a mix of different things, not just one. Studies on semaglutide and tirzepatide show that total weight loss includes both fat and lean mass, with lean mass making up a notable part. The exact breakdown changes from study to study, depending on who was studied, how long the study lasted, and how measurements were taken. This isn't just about GLP-1s—any long-term calorie deficit will cause a similar mix of fat and lean mass loss. What we don't know as much about is how resistance training and muscle-sparing strategies work alongside the strong appetite suppression these drugs cause, which can lower food intake much more than in a typical diet.

Why "Lean Mass" Doesn't Mean Pure Muscle​

In the gym, people often use "lean mass" to mean muscle, but in body composition science, it includes everything that's not fat, like water, organ tissue, connective tissue, glycogen-bound water, and skeletal muscle. DEXA scans, which are commonly used in GLP-1 trials, can't tell muscle protein apart from the other parts of lean mass. This is a key misunderstanding in the gym debate: a drop in lean mass doesn't always mean muscle loss.

This difference matters, especially for contest prep, since water shifts and glycogen loss can already affect scan results. It also makes it harder to preserve muscle, because appetite suppression and changes in training mean you can't always tell what you're losing or keeping.

Any Hard Cut Costs Muscle, Drugs or Not​

Once you set aside the measurement issues, one thing is clear: any aggressive calorie deficit, with or without a GLP-1 RA, will lower both lean mass and fat. This is just how dieting works, not a special side effect of the drug. How much lean mass you keep depends on how fast you lose weight, your protein intake, and your resistance training. The real challenge is appetite. When you eat much less, it's hard to get enough protein and fuel for training. Eating less can also hurt your training quality and recovery, no matter why you're in a deficit. It's hard to separate the drug's effects from the effects of the calorie deficit itself, since research on trained athletes hasn't been able to clearly show the difference.

Why Lifters Weren't the Ones Studied​

Who took part in these trials matters as much as what was measured. The semaglutide and tirzepatide studies mostly included people who were obese or had type 2 diabetes, and most were sedentary or only lightly active. These were not lean, resistance-trained lifters with a lot of muscle. Their body composition was very different—a starting point of 32% body fat is nothing like a well-trained athlete at 10%. There was little structured resistance training in these studies, and even less athlete monitoring, like repeated DEXA scans or performance tests. Weight regain after stopping the drug was tracked in the general population, not in lifters going back to bulking. So, you need to be cautious about applying these results to contest prep athletes. The current evidence doesn't really support that.

Counterfeits, Compounding, and Anti-Doping Risk​

Approved semaglutide and tirzepatide are prescription-only and made to high standards in pharmacies. Anything outside that system may not have verified purity, concentration, or sterility. Some compounded versions exist in a legal gray area. Sometimes, pharmacies make these during shortages, but other times, they are fake products—mislabelled or underdosed—sold online with no quality control. Regulators have a hard time monitoring these grey market suppliers, so consumers face unknown risks.

For athletes who are tested, this is crucial for testing integrity. Federation and WADA policies hold athletes strictly responsible, no matter if the product was legitimate or prescribed. Athletes must check the substance, know the federation's rules, and understand that saying "I didn't know what was in it" is not a valid defense in a doping review.